Targeting human immunodeficiency virus type 1 assembly, maturation and budding
{{output}}
The targets for licensed drugs used for the treatment of human immunodeficiency virus type 1 (HIV-1) are confined to the viral reverse transcriptase (RT), protease (PR), and the gp41 transmembrane protein (TM). While currently approved drugs are effective in c... ...
